Parallel Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $804 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $278 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $11K | Sell |
|
|||||
|
2021
Q4 | $56K | Sell |
|
|||||
|
2021
Q3 | $43K | Buy |
|
|||||
|
2021
Q2 | $4K | Buy |
|
|||||
|
2021
Q1 | $2K | Hold |
|
|||||
|
2020
Q4 | $2K | Sell |
|
|||||
|
2020
Q3 | $5K | Buy |
|
|||||
|
2020
Q2 | $1K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $28K | Buy |
|